Folger Nolan Fleming Douglas Capital Management Inc. Has $21.44 Million Holdings in The Chemours Company (NYSE:CC)

Folger Nolan Fleming Douglas Capital Management Inc. decreased its holdings in shares of The Chemours Company (NYSE:CC) by 5.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 679,826 shares of the specialty chemicals company’s stock after selling 41,736 shares during the quarter. Chemours comprises approximately 2.3% of Folger Nolan Fleming Douglas Capital Management Inc.’s holdings, making the stock its 7th largest position. Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in Chemours were worth $21,442,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in CC. CWM LLC grew its holdings in shares of Chemours by 41.3% during the 3rd quarter. CWM LLC now owns 3,495 shares of the specialty chemicals company’s stock worth $98,000 after purchasing an additional 1,021 shares in the last quarter. IFP Advisors Inc grew its holdings in shares of Chemours by 39.0% during the 3rd quarter. IFP Advisors Inc now owns 2,232 shares of the specialty chemicals company’s stock worth $63,000 after purchasing an additional 626 shares in the last quarter. Avior Wealth Management LLC acquired a new stake in shares of Chemours during the 3rd quarter worth approximately $80,000. Oak Thistle LLC acquired a new stake in shares of Chemours during the 3rd quarter worth approximately $467,000. Finally, Commonwealth Equity Services LLC grew its holdings in shares of Chemours by 1.8% during the 3rd quarter. Commonwealth Equity Services LLC now owns 77,617 shares of the specialty chemicals company’s stock worth $2,177,000 after purchasing an additional 1,360 shares in the last quarter. Institutional investors own 76.26% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on CC shares. BMO Capital Markets raised Chemours from an “underperform” rating to an “outperform” rating and lifted their price objective for the stock from $19.00 to $34.00 in a report on Tuesday, April 9th. UBS Group boosted their price target on Chemours from $21.00 to $28.00 and gave the company a “neutral” rating in a research note on Tuesday, April 2nd. Finally, Barclays decreased their price target on Chemours from $32.00 to $30.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 2nd. Seven analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $30.89.

Chemours Stock Performance

CC traded up $0.29 during trading on Friday, hitting $27.32. The company’s stock had a trading volume of 776,635 shares, compared to its average volume of 1,222,749. The firm’s 50 day moving average price is $26.72 and its two-hundred day moving average price is $27.79. The company has a current ratio of 1.54, a quick ratio of 1.00 and a debt-to-equity ratio of 5.40. The Chemours Company has a 12 month low of $15.10 and a 12 month high of $39.05.

Chemours (NYSE:CC) last issued its quarterly earnings data on Wednesday, March 27th. The specialty chemicals company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.02. Chemours had a positive return on equity of 51.73% and a negative net margin of 3.80%. The firm had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. Sell-side analysts predict that The Chemours Company will post 2.23 EPS for the current fiscal year.

Chemours Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were given a $0.25 dividend. The ex-dividend date was Friday, February 23rd. This represents a $1.00 annualized dividend and a yield of 3.66%. Chemours’s payout ratio is -64.52%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.